Corpus Intelligence IC Memo — NEA BAPTIST MEMORIAL HOSPITAL 2026-04-26 04:02 UTC
IC Memo — NEA BAPTIST MEMORIAL HOSPITAL
Investment Committee Memorandum | AR | 180 beds | Grade C | EBITDA uplift $18.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

NEA BAPTIST MEMORIAL HOSPITAL

CCN 040118 | CRAIGHEAD, AR | 180 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

NEA BAPTIST MEMORIAL HOSPITAL is a 180-bed suburban community hospital in CRAIGHEAD, AR with $246.7M in net patient revenue and a 1.0% operating margin. The hospital serves a payer mix of 37.9% Medicare, 9.1% Medicaid, and 53.0% commercial.

Thesis: Undervalued. Our ML models identify $18.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.0% to 8.4% (+736bps).

Net Revenue HCRIS$246.7M
Current EBITDA COMPUTED$2.5M
Operating Margin COMPUTED1.0%
Occupancy HCRIS84.1%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS18.6%
Distress Probability ML40.8%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
24
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 1.0% places it above the state median. Among 24 size-comparable peers (90-360 beds), the median margin is 0.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (90-360), prioritizing same-state peers. 24 hospitals in the comp set.

HospitalStateBedsRevenueMargin
NEA BAPTIST MEMORIAL HOSPITAL (Target)AR180$246.7M1.0%
ARKANSAS CHILDRENS HOSPITALAR326$759.4M7.9%
MERCY HOSPITAL FORT SMITHAR256$447.1M13.8%
MERCY MEDICAL CENTERAR236$366.7M7.7%
NORTHWEST MEDICAL CENTERAR321$293.1M0.7%
BAXTER REGIONAL MEDICAL CENTERAR169$282.2M-2.8%
BAPTIST HEALTH MEDICAL CENTER AR320$279.1M-13.1%
BAPTIST HEALTH MEDICAL CENTER-AR200$278.0M0.2%
ST. VINCENT HOT SPRINGSAR220$258.6M6.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $18.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.2M+210bp18mo
Cost to Collect4.5%2.5%$4.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.0M+122bp9mo
Clean Claim Rate88.0%96.0%$158K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.2M
Cost to Collect
$4.9M
Denial Rate Reduction
$4.9M
A/R Days Reduction
$3.0M
Clean Claim Rate
$158K
Total EBITDA Uplift$18.2M
Current EBITDA$2.5M
+ RCM Uplift+$18.2M
Pro Forma EBITDA$20.6M
Current Margin1.0%
Pro Forma Margin8.4%
WC Released (1x)$9.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.8M$197.9M51.99x120.4%
Base (11x exit)10.0x11.0x$3.8M$219.0M57.51x124.9%
Bull Case9.0x11.0x$3.4M$280.1M81.75x141.3%
Bull (12x exit)9.0x12.0x$3.4M$306.6M89.48x145.7%
Bear Case11.0x10.0x$4.2M$105.9M25.28x90.8%
Bear (11x exit)11.0x11.0x$4.2M$117.8M28.14x94.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 24 hospitals with 90-360 beds
  • Same-state prioritization (n=25)
  • Comp margins: P25=-12.2% / P50=0.4% / P75=6.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.